Martijn Meijerink

Dr. Martijn Meijerink, an interventional radiologist from Amsterdam UMC and principal investigator of the COLLISION Trial, discusses groundbreaking findings in metastatic colorectal cancer treatment. He emphasizes the potential of thermal ablation as a minimally invasive alternative to surgical resection. The dialogue reveals how advancing techniques, such as radiofrequency and microwave ablation, could reshape clinical practices. Dr. Meijerink also highlights the importance of standardizing care and interdisciplinary collaboration in improving patient outcomes.